SCHEMBL22040865

SCHEMBL22040865

Cc1cccc(OCCNC(=O)COc2ccc(CC(=O)O)cc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARD Q03181 1/20 1.00
▸ KDM4E B2RXH2 1/20 0.63
▸ HPGD P15428 1/20 0.55
▸ MAPT P10636 2/20 0.54
▸ POLB P06746 2/20 0.54
▸ KMT2A Q03164 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ HSD17B10 Q99714 1/20 0.52
▸ TSHR P16473 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ PTPN1 P18031 1/20 0.51
▸ MAPK1 P28482 2/20 0.50
▸ DVL1 O14640 1/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ DRD4 P21917 1/20 0.50
▸ NPY1R P25929 1/20 0.50
▸ GAA P10253 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26382364 0.91 PPARD (0.83) PPARDKDM4EHPGDMAPTPOLB
SCHEMBL15870732 0.75 KMT2A (0.73) PPARDKDM4EHPGDMAPTKMT2A
SCHEMBL8846503 0.75 PPARD (0.60) PPARDHPGDMAPTPOLBKMT2A
SCHEMBL24323517 0.75 PPARD (0.59) PPARDKDM4EMAPTPOLBKMT2A
SCHEMBL13458590 0.75 KMT2A (0.67) PPARDHPGDMAPTPOLBKMT2A
SCHEMBL17164070 0.75 POLB (0.66) PPARDKDM4EHPGDPOLBKMT2A
SCHEMBL16384637 0.74 ALDH1A1 (0.63) PPARDMAPTPOLBKMT2AMEN1
SCHEMBL24322995 0.74 PPARD (0.58) PPARDKDM4EMAPTPOLBKMT2A
SCHEMBL17277318 0.73 POLB (0.68) PPARDHPGDPOLBKMT2AMEN1
SCHEMBL9192309 0.73 ALOX15 (0.76) PPARDKDM4EGAALTB4RLTB4R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11771702-B2 Agonists of PPAR-δ Goldblum, Amiram (IL) 2023-10-03 — — US disclosed
US-11771702-B2 Agonists of PPAR-δ Goldblum, Amiram (IL) 2023-10-03 — — US disclosed
US-20220023308-A1 AGONISTS OF PPAR-delta YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2022-01-27 — — US disclosed
WO-2020110126-A1 AGONISTS OF PPAR-δ YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2020-06-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11771702-B2 Agonists of PPAR-δ PPARD, PPARA, PPARG PPARD 1/4885KDM4E 4373/4885HPGD 771/4885
US-20220023308-A1 AGONISTS OF PPAR-delta PPARD, PPARG, PPARA PPARD 1/4885KDM4E 4447/4885HPGD 715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback